Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

ChemGenics/Wyeth-Ayerst antibacterial drug discovery collaboration

Dec. 6, 1996

New azole antifungal agents described by Zambon

Dec. 4, 1996

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...